Manufacturer record
Aagya Biotech Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Aagya Biotech Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between March 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
7 records linked to Aagya Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Mefenamic Acid Tablets B.P. 500 mg, | T-2506151Mfg 2025-06 · Exp 2027-05 | The Sample does not confirms to BP standards with respect to the test DisintegrationDisintegration | RDTL ErnakulamState lab | Jun 2026 |
| Paracetamol Tablets IP 500 mg | GAB2566Mfg 2023-11 · Exp 2026-10 | DescriptionDescription | SDT&RL, BhubaneswarState lab | May 2026 |
| Ofloxacin and Ornidazole tablets IP (Oflacin-OZ) | T-2406084Mfg 2024-06 · Exp 2027-05 | DescriptionDescription | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Aceclofenac & Paracetamol Tablets (Aceflam P) | T-2403035Mfg 2024-03 · Exp 2027-02 | On visual inspection, presence of spot was observed on tablets surface. The sample received does not conform as per IP 2022 with respect to Description.Description | State Lab PuducherryState lab | Apr 2025 |
| Folic Acid Tablets IP 5 mg (FOLITAS) | T-2406004Mfg 2024-06 · Exp 2026-05 | "Hydrolysis products (N-(4- aminobenzoyl)- L-Glutamic acid)"Other | CDTL MumbaiCDSCO lab | Nov 2024 |
| Ornizole (Ornidazole Tablets I.P. 500 mg) | T-1710151Mfg 2017-10 · Exp 2019-09 | DescriptionDescription | CDL KolkataCDSCO lab | Aug 2019 |
| AMOXYCILLIN & DICLOXACILLIN CAPSULES (ELMOX-PLUS) | AB7003Mfg 2017-05 · Exp 2019-04 | Physical ParameterOther | RDTL GuwahatiState lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.